13F Pro Quality Score

46.4/100

Rank #1,830 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

27.4/100

Profitability

48.5/100

Balance Sheet

33.3/100

Earnings Quality

97.4/100

Free Cash Flow

49.2/100

Institutional Flow

0.3/100

Revenue Scale

51.0/100

Dilution Risk

45.1/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

EHAB Stock Analysis & AI Quality Score

Data updated 2026-08-29

AI stock analysis and institutional research for Enhabit, Inc. (EHAB), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EHAB at 46.4/100 on a 32-signal composite quality model, placing it at rank #1,830 of 2,962 stocks — the bottom half of the AI-ranked universe. EHAB scores in the top quartile across earnings quality (97.4). Areas of concern include institutional flow (0.3) and revenue growth (27.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Enhabit, Inc. reports quarterly revenue of $264.8M, net income of $19.2M, free cash flow of $32.7M. Top institutional holders of EHAB by reported 13-F value include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock, BALYASNY ASSET MANAGEMENT L.P., based on the most recent SEC filings. EHAB trades on the NYSE exchange and files with the SEC under CIK 1803737. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EHAB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Enhabit, Inc. directly from SEC EDGAR. Enhabit, Inc.'s 13F Pro composite quality score has ranged between 32 and 51 since 2023, currently 46.4 — a stable long-term trajectory across 58 quarterly and live scoring snapshots.

Revenue

Q1 2026

$264.8M

Net Income

Q1 2026

$19.2M

Free Cash Flow

Q1 2026

$32.7M

ROIC

Q1 2026

11.9%

D/E Ratio

Q1 2026

0.77

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+2.4% YoY
$1.06BFY 2025
FY22 $1.07BFY23 $1.05BFY24 $1.03BFY25 $1.06B

Net Income

+97.1% YoY
$-4.6MFY 2025
FY22 $-40.4MFY23 $-80.5MFY24 $-156.2MFY25 $-4.6M

Operating Income

+114.0% YoY
$16.1MFY 2025
FY22 $-11.4MFY23 $-47.6MFY24 $-115.1MFY25 $16.1M

EPS (Diluted)

+97.1% YoY
$-0.09FY 2025
FY22 $-0.81FY23 $-1.61FY24 $-3.11FY25 $-0.09

Total Assets

-4.8% YoY
$1.17BFY 2025
FY22 $1.53BFY23 $1.43BFY24 $1.23BFY25 $1.17B

Total Debt

-13.0% YoY
$448.3MFY 2025
FY22 $583.1MFY23 $552.6MFY24 $515.4MFY25 $448.3M

Op. Cash Flow

+38.1% YoY
$70.7MFY 2025
FY22 $80.1MFY23 $48.4MFY24 $51.2MFY25 $70.7M

Free Cash Flow

+38.8% YoY
$65.8MFY 2025
FY22 $73.0MFY23 $44.9MFY24 $47.4MFY25 $65.8M

Get alerted when EHAB's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Enhabit, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of EHAB

Companies Similar to EHAB

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

INNV

InnovAge Holding Corp.

51
AI score
Similar quality profile · 1 shared holders
INGN

Inogen Inc

33
AI score
Similar quality profile · 1 shared holders
PRGO

PERRIGO Co plc

33
AI score
Similar quality profile · 1 shared holders
IART

INTEGRA LIFESCIENCES HOLDINGS CORP

45
AI score
Similar quality profile
ARAY

ACCURAY INC

26
AI score
Similar quality profile
TNDM

TANDEM DIABETES CARE INC

40
AI score
Similar quality profile · 1 shared holders
NEOG

NEOGEN CORP

42
AI score
Similar quality profile
FTRE

Fortrea Holdings Inc.

44
AI score
Similar quality profile

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put EHAB on your watchlist

Track score changes the day Enhabit, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is EHAB a good stock to buy?

13F Pro's AI-powered analysis of Enhabit, Inc. (EHAB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EHAB are available on the EHAB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. EHAB is classified as a small company.

Which hedge funds own EHAB?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EHAB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Enhabit, Inc.'s investment landscape.